Last10K.com

Mediwound Ltd. (MDWD) SEC Filing 6-K Foreign Issuer Report for the period ending Tuesday, May 17, 2022

Mediwound Ltd.

CIK: 1593984 Ticker: MDWD

View differences made from one to another to evaluate Mediwound Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mediwound Ltd..

Continue

Assess how Mediwound Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Mediwound Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Mediwound Ltd. provided additional information to their SEC Filing as exhibits

Ticker: MDWD
CIK: 1593984
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001178913-22-002039
Submitted to the SEC: Tue May 17 2022 7:06:32 AM EST
Accepted by the SEC: Tue May 17 2022
Period: Tuesday, May 17, 2022
Industry: Medicinal Chemicals And Botanical Products

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/mdwd/0001178913-22-002039.htm